Cargando…

Hypertension and Covid-19 vaccines: are there any differences between the different vaccines? A safety signal

Detalles Bibliográficos
Autores principales:	Bouhanick, Beatrice, Montastruc, François, Tessier, Samuel, Brusq, Clara, Bongard, Vanina, Senard, Jean-Michel, Montastruc, Jean-Louis, Herin, Fabrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346776/ https://www.ncbi.nlm.nih.gov/pubmed/34363519 http://dx.doi.org/10.1007/s00228-021-03197-8

Ejemplares similares

COVID-19 vaccines: A perspective from social pharmacology
por: Montastruc, Jean-Louis, et al.
Publicado: (2021)

Adverse drug reactions and ivermectin in COVID-19
por: Montastruc, Jean-Louis
Publicado: (2022)

Interactions between Medical Residents and Drug Companies: A National Survey after the Mediator® Affair
por: Montastruc, François, et al.
Publicado: (2014)

Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: A missed opportunity for a rapid return of experience
por: Geeraerts, Thomas, et al.
Publicado: (2021)

Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France
por: Montastruc, François, et al.
Publicado: (2020)

Cancer Risk of Anti-TNF-α at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses
por: Moulis, Guillaume, et al.
Publicado: (2012)

A New Drug–Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database
por: Berthet, Stephanie, et al.
Publicado: (2011)

Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019
por: Montastruc, François, et al.
Publicado: (2020)

Perception of teratogenic and foetotoxic risk by health professionals: a survey in Midi-Pyrenees area
por: Damase-Michel, Christine, et al.
Publicado: (2008)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Increased reporting of venous and arterial thromboembolic events reported with tixagevimab–cilgavimab for coronavirus disease 2019
por: Montastruc, François, et al.
Publicado: (2023)

Quality of reporting of adverse events in clinical trials of covid-19 drugs: systematic review
por: Madi, Karima, et al.
Publicado: (2023)

The Cost of Potentially Inappropriate Medications in Nursing Homes in West Occitanie
por: Caucat, Marie, et al.
Publicado: (2020)

Case Report: A Case of Valproic Acid-Induced Hyperammonemic Encephalopathy Associated With the Initiation of Lithium: A Re-duplicable Finding
por: Levy, Anna, et al.
Publicado: (2022)

Laboratory Monitoring of Patients Treated with Antihypertensive Drugs and Newly Exposed to Non Steroidal Anti-Inflammatory Drugs: A Cohort Study
por: Fournier, Jean-Pascal, et al.
Publicado: (2012)

French Pharmacovigilance Public System and COVID-19 Pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020)

Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case–noncase study
por: Chouchana, Laurent, et al.
Publicado: (2021)

Is Vaccination Any Use?
Publicado: (1923)

Adhésion à la vaccination contre le SARS-CoV-2 chez les professionnels du CHU de Toulouse
por: Sommé, Jérémie, et al.
Publicado: (2022)

Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?
por: Concordet, Didier, et al.
Publicado: (2019)

Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns
por: Touafchia, Anthony, et al.
Publicado: (2021)

COVID-19 infection among vaccinated and unvaccinated: Does it make any difference?
por: Fatima, Samar, et al.
Publicado: (2022)

Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
por: Revet, Alexis, et al.
Publicado: (2020)

Authors’ Reply to Castello-Bridoux et al.: “Comment on Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Nicolas: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Coste et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Lechat et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Nicolas: “Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Yu et al.: “Levothyrox(®) New and Old Formulations: Are They Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study
por: Garcia, Philippe, et al.
Publicado: (2020)

French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19)
por: de Canecaude, Claire, et al.
Publicado: (2023)

Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial
por: Defer, Gilles, et al.
Publicado: (2018)

The impact of COVID-19 vaccination on stock market: is there any difference between developed and developing countries?
por: Oanh, Tran Thi Kim
Publicado: (2022)

Drug–drug interactions with imatinib: An observational study
por: Récoché, Isabelle, et al.
Publicado: (2016)

Any progress for HIV vaccines to come?
por: Wigzell, Hans
Publicado: (2006)

Vaccines for endoparasites: Any hope on the horizon?
Publicado: (2019)

Diabetes and COVID-19
por: Bouhanick, Béatrice, et al.
Publicado: (2020)

Diabète et COVID-19
por: Bouhanick, Béatrice, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hs6cgnipg0lms959lg1mro3ibm